Introduction: the scientific and clinical rationale for extended acid suppression

被引：0
|
作者：
Katz, Philip O. [1 ]
机构：
[1] Albert Einstein Med Ctr, Div Gastroenterol, Philadelphia, PA 19141 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2006年 / 23卷
关键词：
D O I：
10.1111/j.1365-2036.2006.02942.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [1] Introduction to Immunologic Checkpoints for Cancer Treatment: From Scientific Rationale to Clinical Application
    Maio, Michele
    SEMINARS IN ONCOLOGY, 2010, 37 (05) : 429 - 429
  • [2] The Scientific Rationale for the Introduction of Renalase in the Concept of Cardiac Fibrosis
    Stojanovic, Dijana
    Mitic, Valentina
    Stojanovic, Miodrag
    Milenkovic, Jelena
    Ignjatovic, Aleksandra
    Milojkovic, Maja
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [3] Intravenous ascorbic acid protocol for cancer patients: scientific rationale, pharmacology, and clinical experience
    Mikirova, N. A.
    Casciari, J. J.
    Hunninghake, R. E.
    Riordan, N. H.
    FUNCTIONAL FOODS IN HEALTH AND DISEASE, 2013, 3 (08): : 344 - 366
  • [4] Intermittent androgen suppression: Rationale and clinical experience
    Gleave, M
    Bruchovsky, N
    Goldenberg, SL
    Rennie, P
    RECENT ADVANCES IN PROSTATE CANCER AND BPH, 1997, : 109 - 120
  • [5] Scientific rationale and clinical development of sunitinib malate
    Ueda, Eiji
    Casali, Paolo G.
    Demetri, George D.
    Hudes, Gary R.
    Kulke, Matthew H.
    Miller, Kathy D.
    Motzer, Robert J.
    Baum, Charles M.
    CLINICAL & EXPERIMENTAL METASTASIS, 2007, 24 (04) : 218 - 219
  • [6] THE RATIONALE OF ACID SUPPRESSION IN THE TREATMENT OF ACID-RELATED DISEASE
    MOHAMED, AH
    HUNT, RH
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1994, 8 : 3 - 10
  • [7] Continuous positive airway pressure: scientific and clinical rationale
    Morley, Colin J.
    Davis, Peter G.
    CURRENT OPINION IN PEDIATRICS, 2008, 20 (02) : 119 - 124
  • [8] Changing the nomenclature/taxonomy for intersex: A scientific and clinical rationale
    Dreger, AD
    Chase, C
    Sousa, A
    Gruppus, PA
    Frader, J
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2005, 18 (08): : 729 - 733
  • [9] Scientific Rationale for Waiving Clinical Efficacy Testing of Biosimilars
    Niazi, Sarfaraz
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 2803 - 2815
  • [10] Preventing clinical heart failure: the rationale and scientific evidence
    Wood, DA
    HEART, 2002, 88 : 15 - 21
12345